These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 2855852)

  • 1. Structure activity studies of two classes of beta-amino-amides: the search for kappa-selective opioids.
    Loew G; Lawson J; Toll L; Frenking G; Berzetei-Gurske I; Polgar W
    NIDA Res Monogr; 1988; 90():144-51. PubMed ID: 2855852
    [No Abstract]   [Full Text] [Related]  

  • 2. Activity of mu- and delta-selective opioid agonists in the guinea pig ileum preparation: differentiation into peptide and nonpeptide classes with beta-funaltrexamine.
    Ward SJ; LoPresti D; James DW
    J Pharmacol Exp Ther; 1986 Aug; 238(2):625-31. PubMed ID: 3016244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kappa opioid properties of dynorphin and its peptide fragments on the guinea-pig Ileum.
    Yoshimura K; Huidobro-Toro JP; Lee NM; Löh HH; Way EL
    J Pharmacol Exp Ther; 1982 Jul; 222(1):71-9. PubMed ID: 6123594
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of dynorphin-selective Kappa receptors in mouse vas deferens and guinea pig ileum. Spare receptor fraction as a determinant of potency.
    Cox BM; Chavkin C
    Mol Pharmacol; 1983 Jan; 23(1):36-43. PubMed ID: 6135144
    [No Abstract]   [Full Text] [Related]  

  • 5. Ring-constrained orvinols as analogs of buprenorphine: differences in opioid activity related to configuration of C(20) hydroxyl group.
    Traynor JR; Guo L; Coop A; Lewis JW; Woods JH
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1093-9. PubMed ID: 10565829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bimorphinans as highly selective, potent kappa opioid receptor antagonists.
    Portoghese AS; Lipkowski AW; Takemori AE
    J Med Chem; 1987 Feb; 30(2):238-9. PubMed ID: 3027336
    [No Abstract]   [Full Text] [Related]  

  • 7. Activation of K-opiate sites by dynorphin in the myenteric plexus.
    Yoshimura K; Huidobro-Toro JP; Lee NM; Loh HH; Way EL
    Adv Biochem Psychopharmacol; 1982; 33():91-8. PubMed ID: 6127009
    [No Abstract]   [Full Text] [Related]  

  • 8. Probes for narcotic receptor-mediated phenomena. 25. Synthesis and evaluation of N-alkyl-substituted (alpha-piperazinylbenzyl)benzamides as novel, highly selective delta opioid receptor agonists.
    Katsura Y; Zhang X; Homma K; Rice KC; Calderon SN; Rothman RB; Yamamura HI; Davis P; Flippen-Anderson JL; Xu H; Becketts K; Foltz EJ; Porreca F
    J Med Chem; 1997 Aug; 40(18):2936-47. PubMed ID: 9288176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational design and biological properties of highly specific mu and delta opioid peptides.
    Roques BP; Fournié-Zaluski MC; Gacel G; David M; Meunier JC; Maigret B; Morgat JL
    Adv Biochem Psychopharmacol; 1982; 33():321-31. PubMed ID: 6289629
    [No Abstract]   [Full Text] [Related]  

  • 10. Design, synthesis, and biological activities of cyclic lactam peptide analogues of dynorphine A(1-11)-NH2.
    Lung FD; Collins N; Stropova D; Davis P; Yamamura HI; Porreca F; Hruby VJ
    J Med Chem; 1996 Mar; 39(5):1136-41. PubMed ID: 8676350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. QSAR analysis of chiral compounds including racemates.
    Schaper KJ
    Prog Clin Biol Res; 1989; 291():41-4. PubMed ID: 2542981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid mu, delta, and kappa receptor-induced activation of phospholipase C-beta 3 and inhibition of adenylyl cyclase is mediated by Gi2 and G(o) in smooth muscle.
    Murthy KS; Makhlouf GM
    Mol Pharmacol; 1996 Oct; 50(4):870-7. PubMed ID: 8863832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholinergic compounds. 9. Cyclohexane analogues of deoxamuscarine and derivatives.
    Angeli P; Melchiorre C; Giannella M; Pigini M; Cingolani ML
    J Med Chem; 1977 Mar; 20(3):398-400. PubMed ID: 845872
    [No Abstract]   [Full Text] [Related]  

  • 14. An assessment of parameters in QuaSAR studies of narcotic analgesics and antagonists.
    Katz R; Osborne S; Ionescu F; Andrulis P; Bates R; Beavers W; Chou PC; Loew G; Berkowitz D
    NIDA Res Monogr; 1978; (22):441-63. PubMed ID: 30912
    [No Abstract]   [Full Text] [Related]  

  • 15. Reversible and irreversible binding of beta-funaltrexamine to mu, delta and kappa opioid receptors in guinea pig brain membranes.
    Tam SW; Liu-Chen LY
    J Pharmacol Exp Ther; 1986 Nov; 239(2):351-7. PubMed ID: 3021954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of biological activities of enkephalin analogues in isolated organs.
    Friedmann T; Medzihradszky K; Kovács A; Kerecsen L; Szécsi JH; Di Gléria K; Knoll J
    Pol J Pharmacol Pharm; 1982; 34(1-3):53-61. PubMed ID: 6300815
    [No Abstract]   [Full Text] [Related]  

  • 17. [Synthesis and H2-antagonistic action of N3, N5-substituted 1,2, 4-oxadiazole-3, 5-diamine. 26. H2-antihistaminics].
    Krämer I; Schunack W
    Arzneimittelforschung; 1986 Jul; 36(7):1011-4. PubMed ID: 2876712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Properties of the putative epsilon opioid receptor: identification in rat, guinea pig, cow, pig and chicken brain.
    Nock B; Giordano AL; Moore BW; Cicero TJ
    J Pharmacol Exp Ther; 1993 Jan; 264(1):349-59. PubMed ID: 8380865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationships of opioid peptides.
    Morley JS; Dutta AS
    NIDA Res Monogr; 1986; 69():42-64. PubMed ID: 3020417
    [No Abstract]   [Full Text] [Related]  

  • 20. Side chain methyl substitution in the delta-opioid receptor antagonist TIPP has an important effect on the activity profile.
    Tourwé D; Mannekens E; Diem TN; Verheyden P; Jaspers H; Tóth G; Péter A; Kertész I; Török G; Chung NN; Schiller PW
    J Med Chem; 1998 Dec; 41(26):5167-76. PubMed ID: 9857087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.